Reduced difference of α 2-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to anti-factor XIII antibodies

International Journal of Hematology

Volumn 95, Issue 1, 2012, Pages 47-50

  Ichinose, Akitada ^a   Souri, Masayoshi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Acquired deficiency; Anti fibrinolytic potency; Autoantibodies; Bleeding disorder; Nationwide study; Protein cross linking

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIBODY; BLOOD CLOTTING FACTOR 13 ANTIBODY; FIBRIN; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNE HEMORRHAPHILIA; BLOOD CLOTTING FACTOR 13 DEFICIENCY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CROSS LINKING; EX VIVO STUDY; HEMATOLOGIC DISEASE; HUMAN; PROTEIN BLOOD LEVEL;

ALPHA-2-ANTIPLASMIN; AUTOANTIBODIES; AUTOIMMUNITY; BIOLOGICAL MARKERS; FACTOR XIII; FACTOR XIII DEFICIENCY; HUMANS; JAPAN; PLASMA; SERUM; SEVERITY OF ILLNESS INDEX;

EID: 84857632288     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0992-7     Document Type: Conference Paper

References (16)

1. LN Boggio D Green 2001 Acquired hemophilia Rev Clin Exp Hematol 5 389 404 11844135 10.1046/j.1468-0734.2001.00049.x 1:STN:280:DC%2BD387htVKlsw%3D%3D (Pubitemid 34947697)
2. D Green K Lechner 1981 A survey of 215 non-hemophilic patients with inhibitors to Factor VIII Thromb Haemost 45 200 203 6792737 1:STN:280: DyaL38%2FhvVWlsw%3D%3D (Pubitemid 11081028)
3. AJ Cohen CM Kessler 1996 Acquired inhibitors Baillieres Clin Haematol 9 331 354 8800509 10.1016/S0950-3536(96)80067-9 1:STN:280:DyaK28zptlOgtA%3D%3D (Pubitemid 26185952)
4. D Green 2000 Spontaneous inhibitors to coagulation factors Clin Lab Haematol 22 Suppl 1 21 25 11251655 10.1046/j.1365-2257.2000.00001.x (Pubitemid 32047114)
5. PW Collins S Hirsch TP Baglin G Dolan J Hanley M Makris UK Haemophilia Centre Doctors' Organisation 2007 Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation Blood 109 1870 1877 17047148 10.1182/blood-2006-06-029850 1:CAS:528:DC%2BD2sXjtFeqt7Y%3D (Pubitemid 46348182)
6. A Ichinose 2011 Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited Semin Thromb Hemost 37 382 388 21805444 10.1055/s-0031-1276587 1:CAS:528:DC%2BC3MXps1Oqs7o%3D
7. A Ichinose M Souri Japanese collaborative research group on "Acquired haemorrha-philia due to factor XIII deficiency" 2011 As many as 12 cases with haemorrhagic acquired factor XIII deficiency due to its inhibitors were recently found in Japan Thromb Haemost 105 925 927 21264450 10.1160/TH10-11-0724 1:CAS:528:DC%2BC3MXns1Sks7w%3D
8. M Souri S Koseki-Kuno N Takeda JL Degen A Ichinose 2008 Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice Int J Hematol 87 60 68 18224415 10.1007/s12185-007-0005-z 1:CAS:528:DC%2BD1cXovV2ru7w%3D
9. Y Sakata K Tateno T Tamaki N Aoki 1979 Calcium-dependent binding of alpha 2-plasmin inhibitor to fibrin Thromb Res 16 279 282 505425 10.1016/0049- 3848(79)90291-3 1:CAS:528:DyaL3cXjvVOk (Pubitemid 10189989)
10. Y Sakata N Aoki 1980 Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor J Clin Invest 65 290 297 6444305 10.1172/JCI109671 1:CAS:528:DyaL3cXht1Gqsb4%3D (Pubitemid 10159859)
11. Y Sakata N Aoki 1982 Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis J Clin Invest 69 536 542 7199538 10.1172/JCI110479 1:CAS:528:DyaL38XhtF2qs78%3D (Pubitemid 12184949)
12. NJ Mutch JS Koikkalainen SR Fraser KM Duthie M Griffin J Mitchell, et al. 2010 Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysis J Thromb Haemost 8 2017 2024 20586921 10.1111/j.1538-7836.2010.03963.x 1:CAS:528:DC%2BC3cXht1yrtr7L
13. SR Fraser NA Booth NJ Mutch 2011 The antifibrinolytic function of factor XIII is exclusively expressed through α-antiplasmin cross-linking Blood 117 6371 6374 21471521 10.1182/blood-2011-02-333203
14. K Kasahara M Souri M Kaneda T Miki N Yamamoto A Ichinose 2010 Impaired clot retraction in factor XIII A subunit-deficient mice Blood 115 1277 1279 19996413 10.1182/blood-2009-06-227645 1:CAS:528:DC%2BC3cXisFyrtb0%3D
15. S Koseki-Kuno M Yamakawa G Dickneite A Ichinose 2003 Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages Blood 102 4410 4412 12933578 10.1182/blood-2003-05-1467 1:CAS:528:DC%2BD3sXpslGrsLs%3D (Pubitemid 37494103)
16. M Souri S Koseki-Kuno N Takeda M Yamakawa Y Takeishi JL Degen, et al. 2008 Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII Thromb Haemost 99 401 408 18278192 1:CAS:528: DC%2BD1cXisFKmt7k%3D